Ahmedabad, May 20 -- Torrent Pharmaceuticals Limited on Tuesday announced its financial results for the fourth quarter and full year ended 31 March 2025, reporting steady growth across key metrics. For Q4 FY25, the company posted revenue of Rs 2,959 crore, marking an 8 percent year-on-year increase. Gross margin remained stable at 75.3 percent. Operating EBITDA rose 9 percent to Rs. 964 crore, while net profit after tax climbed 11 percent to Rs. 498 crore. Adjusted for exceptional items and inventory revaluation, operating EBITDA stood at Rs. 981 crore, an 11 percent rise. For the full fiscal year, Torrent reported revenues of Rs 11,516 crore, up 7 percent from the previous year. Operating EBITDA grew 10 percent to Rs. 3,721 crore, with net...